Amylin‑Based Therapeutics Summit | December 1-3, 2026 | Boston, MA The amylin analog space is rapidly expanding in 2026, with new companies entering the field, stealth programs beginning to emerge, and major […]

The World CNS Summit South Korea is the premier industry-focused forum dedicated to advancing targeted, mechanism-differentiated therapies for neurodegenerative, rare neurodevelopmental, and neuropsychiatric disorders. As South Korea emerges as a […]

The 10th Complement-Based Drug Development Summit returns at a pivotal moment as the field shifts from validating complement biology to maximizing its clinical and commercial potential. As pipelines expand beyond […]

Optimizing Tolerability, Quality of Weight Loss & Personalized Therapies to Drive Competitive Drug Development As obesity drug development enters a defining new chapter, the race is no longer about developing […]

The 5th Ophthalmic Drug Delivery Summit is where the innovators behind the next generation of ocular therapies come together to solve one critical challenge: getting the right therapy to the […]

Muscular Disorders Drug Development Summit | January 26-28, 2027 | Boston, MA The muscular disease field is entering a pivotal new chapter. Following a year of significant debate around Sarepta's […]

One year on from Vertex Pharmaceuticals' milestone JOURNAVX® approval, making history as the first new class of pain medicine in decades, non-opioid pain R&D has skyrocketed as one of biopharma’s […]

17th World ADC London | 8-11th March 2027 | London, UK The preliminary agenda for the 17th World ADC London has now been released, offering a first look at the […]